MedPath
HSA Approval

ORATANE CAPSULE 5 mg

SIN14628P

ORATANE CAPSULE 5 mg

ORATANE CAPSULE 5 mg

September 22, 2014

APEX PHARMA MARKETING PTE. LTD.

APEX PHARMA MARKETING PTE. LTD.

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantAPEX PHARMA MARKETING PTE. LTD.
Licence HolderAPEX PHARMA MARKETING PTE. LTD.

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

CAPSULE

ORAL

Medical Information

D10BA01

isotretinoin

Manufacturer Information

APEX PHARMA MARKETING PTE. LTD.

SWISS CAPS AG

Douglas Manufacturing Ltd. (Primary Packaging)

Active Ingredients

ISOTRETINOIN

5MG

Isotretinoin

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

ORATANE CAPSULE 5 mg - HSA Approval | MedPath